Combined treatment with interferon-alpha and ribavirin for subacute sclerosing panencephalitis

Pediatric Neurology

Volumn 24, Issue 1, 2001, Pages 54-59

  Tomoda, Akemi ^a   Shiraishi, Seiji ^a   Hosoya, Mitsuaki ^b   Hamada, Akinobu ^a   Miike, Teruhisa ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; MEASLES ANTIBODY; METHISOPRINOL; RIBAVIRIN;

ADOLESCENT; ARTICLE; AUDIOGRAPHY; BRAIN ATROPHY; CASE REPORT; CEREBROSPINAL FLUID EXAMINATION; DISEASE CLASSIFICATION; DRUG BLOOD LEVEL; DRUG CEREBROSPINAL FLUID LEVEL; DYSPHAGIA; EVOKED SOMATOSENSORY RESPONSE; FEMALE; HOSPITAL ADMISSION; HUMAN; MALE; MEASLES; MONOTHERAPY; MUSCLE HYPERTONIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; SUBACUTE SCLEROSING PANENCEPHALITIS; URINE INCONTINENCE;

ADOLESCENT; BRAIN; CHILD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INJECTIONS, INTRAVENTRICULAR; INTERFERON-ALPHA; MAGNETIC RESONANCE IMAGING; MALE; NEUROLOGIC EXAMINATION; RIBAVIRIN; SUBACUTE SCLEROSING PANENCEPHALITIS;

EID: 0035130645     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-8994(00)00233-2     Document Type: Article

References (17)

1. Subacute sclerosing panencephalitis and chorioretinitis
2. Augmentation by interferon of human natural and antibody dependent cell-mediated cytotoxicity
3. Broad-spectrum synergistic antiviral activity of selenazofurin and ribavirin
4. Long-term follow up of patients with subacute sclerosing panencephalitis treated with intraventricular α-interferon
5. Alpha-interferon and isoprinosine in adult-onset subacute sclerosing panencephalitis
6. Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
7. The cooperative effect of interferon-α and ribavirin on subacute sclerosing panencephalitis (SSPE) virus infections, in vitro and in vivo
8. Intraparenchymal alpha interferon and intraventricular ribavirin for subacute sclerosing panencephalitis (SSPE)
9. SSPE; Clinical staging, course and frequency
10. Long-term follow-up of patients with subacute sclerosing panencephalitis treated with inosiplex
11. Effect of ribavirin on subacute sclerosing panencephalitis virus infections in hamsters
12. Oral ribavirin therapy for subacute sclerosing panencephalitis
13. Successful treatment of disseminated measles in a patients with acquired immunodeficiency syndrome; Consideration of antiviral and passive immunotherapy
14. Subacute measles encephalitis in the young immunocompromised host; Report of two cases diagnosed by polymerase chain reaction and treated with ribavirin and review of the literature
15. Treatment of severe La Crosse encephalitis with intravenous ribavirin following diagnosis by brain biopsy